Last reviewed · How we verify

NCT06918145: LVA; AD

Clinical Study on Lymphaticovenous Anastomosis(LVA) for the Treatment of Alzheimer's Disease(AD)

ENROLLING BY INVITATION NA Last updated 9 April 2025
What this trial tests

NA trial testing Lymphaticovenous Anastomosis in Alzheimer&Amp;#39;s Disease (AD) in 80 participants. Enrolling by invitation.

Timeline
2 April 2025
Primary endpoint
1 March 2030
1 March 2030

Quick facts

Lead sponsorPeking University Third Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment80
Start date2 April 2025
Primary completion1 March 2030
Estimated completion1 March 2030
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Adults 50 to 85, any sex, with Alzheimer&Amp;#39;s Disease (AD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to explore the safety and efficacy of Lymphaticovenous Anastomosis (LVA) for the Treatment of Alzheimer's Disease (AD). The main questions it aims to answer are: 1. After LVA surgery treatment, do patients with AD show improvement in dementia, cognitive impairment, neurobehavioral symptoms? 2. What are the complications associated with LVA treatment for AD, including perioperative complications and long-term complications? 3. What is the mechanism of LVA treatment for AD patients, and what changes occur in AD-related biomarkers (Aβ42、 Aβ40、Aβ42/40、pTau217、pTau181) before and after surgery?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Brain lymphatic drainage pathways, deep cervical lymphatic surgery, and current insights: A systematic review.
    Lahmar T, Thuau F, Pinard G, Boutoleau-Bretonniere C, et al · · 2026 · cited 2× · PMID 40877101 · DOI 10.1016/j.tjpad.2025.100335

Verify or expand the search:

Other trials of Lymphaticovenous Anastomosis

Trials testing the same drug.

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06918145.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing